Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours - PubMed (original) (raw)
. 1997 Aug 14;15(7):871-4.
doi: 10.1038/sj.onc.1201238.
Affiliations
- PMID: 9266974
- DOI: 10.1038/sj.onc.1201238
Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours
P Chattopadhyay et al. Oncogene. 1997.
Abstract
Amongst the human astrocytic tumours, the commonest of primary brain tumours, the clinical outcome of astrocytoma (AS) is significantly better than anaplastic astrocytoma (AA) and glioblastoma multiforme (GBM). Often, low grade tumours can progress to or recur with a more malignant phenotype. Recent loss of heterozygosity (LOH) reports suspect the involvement of a tumour suppressor gene, different from p53, in the 17p13.3 region of the human chromosome. However, the effect of LOH of 17p13.3 region on tumour histology at presentation and prognosis is as yet undefined. As a first step to define the role of this putative oncogene in astrocytic tumour progression, we correlated the LOH of a locus, D17S379, in 17p13.3 region and the p53 locus in 17p13.1 region with the histopathology of astrocytic tumours by PCR based microsatellite and restriction fragment length polymorphism of DNA extracted from microdissected paraffin sections of 45 astrocytic tumours of different histopathological grades. LOH of D17S379 was significantly associated (P=0.02) with AA and GBM (high grade malignancy), while no such preferential association was found with LOH of p53. There were no mutations in the exons 5 to 9 of p53 gene in the five tumours with LOH of D17S379 but not of p53 region. In a case of AA with a heterogenous microscopic appearance, heterozygosity of D17S379 was lost only in the area with a more malignant histology while both areas had no LOH or mutation of p53. A locus at the 17p13.3 region, independent of the p53 locus, is involved in a large subset of astrocytic tumours during transformation into a more malignant phenotype, and thus may be a link in the chain of genetic events occurring in astrocytic tumour progression.
Similar articles
- p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. Fults D, et al. Cancer Res. 1992 Feb 1;52(3):674-9. Cancer Res. 1992. PMID: 1346255 - Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU. Saxena A, et al. Cancer Res. 1992 Dec 1;52(23):6716-21. Cancer Res. 1992. PMID: 1358438 - Genetic alterations associated with glioma progression.
Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H. Kleihues P, et al. Verh Dtsch Ges Pathol. 1994;78:43-7. Verh Dtsch Ges Pathol. 1994. PMID: 7534015 Review. - Gliomas.
Collins VP. Collins VP. Cancer Surv. 1998;32:37-51. Cancer Surv. 1998. PMID: 10489622 Review.
Cited by
- P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells.
Kumar S. Kumar S. Mol Cell Biochem. 2014 Oct;395(1-2):281-90. doi: 10.1007/s11010-014-2137-9. Epub 2014 Jul 4. Mol Cell Biochem. 2014. PMID: 24992983 - Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.
Srivastava T, Chosdol K, Chattopadhayay P, Sarkar C, Mahapatra AK, Sinha S. Srivastava T, et al. J Neurooncol. 2007 Feb;81(3):249-55. doi: 10.1007/s11060-006-9230-1. Epub 2006 Oct 4. J Neurooncol. 2007. PMID: 17019533 - Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer.
Tsuchiya E, Tanigami A, Ishikawa Y, Nishida K, Hayashi M, Tokuchi Y, Hashimoto T, Okumura S, Tsuchiya S, Nakagawa K. Tsuchiya E, et al. Jpn J Cancer Res. 2000 Jun;91(6):589-96. doi: 10.1111/j.1349-7006.2000.tb00986.x. Jpn J Cancer Res. 2000. PMID: 10874210 Free PMC article. - Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
Sarkar C, Karak AK, Nath N, Sharma MC, Mahapatra AK, Chattopadhyay P, Sinha S. Sarkar C, et al. J Neurooncol. 2005 Jun;73(2):93-100. doi: 10.1007/s11060-004-3015-1. J Neurooncol. 2005. PMID: 15981097 - Molecular cloning and expression of high GC-rich novel tumor suppressor gene HIC-1.
Kumar S. Kumar S. Mol Biotechnol. 2014 Nov;56(11):1040-8. doi: 10.1007/s12033-014-9783-8. Mol Biotechnol. 2014. PMID: 25001210
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous